Arcadia Biosciences
(NASDAQ:RKDA)
$1.97
-0.0601[-2.96%]
At close: Apr 24
$1.97
0[0.00%]
After Hours: 8:04AM EDT
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$4.50
Consensus Price Target1
$7.25

Arcadia Biosciences Stock (NASDAQ:RKDA), Analyst Ratings, Price Targets, Predictions

Arcadia Biosciences Inc has a consensus price target of $7.25, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 5, 2024, August 28, 2023, and July 24, 2023. With an average price target of $11.67 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 492.22% upside for Arcadia Biosciences Inc from these 3 analyst ratings.

Analyst Trend
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Lake Street

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Arcadia Biosciences

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
04/05/2024RKDABuy Now
Arcadia Biosciences
$1.97407.61%HC Wainwright & Co.
Raghuram Selvaraju
→ $10ReiteratesBuy → BuyGet Alert
08/28/2023RKDABuy Now
Arcadia Biosciences
$1.97407.61%HC Wainwright & Co.
Raghuram Selvaraju
$15 → $10MaintainsBuyGet Alert
07/24/2023RKDABuy Now
Arcadia Biosciences
$1.97661.42%HC Wainwright & Co.
Raghuram Selvaraju
→ $15ReiteratesBuy → BuyGet Alert
06/05/2023RKDABuy Now
Arcadia Biosciences
$1.97661.42%HC Wainwright & Co.
Raghuram Selvaraju
$18 → $15MaintainsBuyGet Alert
04/14/2023RKDABuy Now
Arcadia Biosciences
$1.97813.71%HC Wainwright & Co.
Raghuram Selvaraju
$3 → $18MaintainsBuyGet Alert
08/26/2022RKDABuy Now
Arcadia Biosciences
$1.9752.28%HC Wainwright & Co.
Raghuram Selvaraju
$160 → $120MaintainsBuyGet Alert
01/03/2022RKDABuy Now
Arcadia Biosciences
$1.97204.57%HC Wainwright & Co.
Raghuram Selvaraju
$280 → $240MaintainsBuyGet Alert
06/01/2021RKDABuy Now
Arcadia Biosciences
$1.97255.33%HC Wainwright & Co.
Raghuram Selvaraju
MaintainsBuyGet Alert
05/11/2021RKDABuy Now
Arcadia Biosciences
$1.97128.43%Lake Street
Ben Klieve
Initiates → BuyGet Alert

FAQ

Q

What is the target price for Arcadia Biosciences (RKDA)?

A

The latest price target for Arcadia Biosciences (NASDAQ: RKDA) was reported by HC Wainwright & Co. on April 5, 2024. The analyst firm set a price target for $10.00 expecting RKDA to rise to within 12 months (a possible 407.61% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Arcadia Biosciences (RKDA)?

A

The latest analyst rating for Arcadia Biosciences (NASDAQ: RKDA) was provided by HC Wainwright & Co., and Arcadia Biosciences reiterated their buy rating.

Q

When was the last upgrade for Arcadia Biosciences (RKDA)?

A

There is no last upgrade for Arcadia Biosciences.

Q

When was the last downgrade for Arcadia Biosciences (RKDA)?

A

There is no last downgrade for Arcadia Biosciences.

Q

When is the next analyst rating going to be posted or updated for Arcadia Biosciences (RKDA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcadia Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcadia Biosciences was filed on April 5, 2024 so you should expect the next rating to be made available sometime around April 5, 2025.

Q

Is the Analyst Rating Arcadia Biosciences (RKDA) correct?

A

While ratings are subjective and will change, the latest Arcadia Biosciences (RKDA) rating was a reiterated with a price target of $0.00 to $10.00. The current price Arcadia Biosciences (RKDA) is trading at is $1.97, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch